Status:
RECRUITING
Real-world Study to Assess Adherence to IOP Lowering Therapy in Glaucoma Patients Using CONNECTDROP®
Lead Sponsor:
Laboratoires Thea
Conditions:
Adherence to Glaucoma Therapy
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this real-life, national, multicentre, prospective clinical investigation is to describe the adherence rate over time in patients with glaucoma already treated with IOP-lowering eye drops ...
Eligibility Criteria
Inclusion
- Adult patient (≥ 18 years old), man or woman
- Patient with a diagnosis of bilateral open angle glaucoma
- Patients being prescribed with glaucoma eye drops in EASYGRIP® bottle for at least 6 weeks in monotherapy.
- Patient willing to participate in the study
- Patient who consents for data collection in the frame of the study
Exclusion
- Pregnant and/or lactating woman
- Patient receiving another ocular treatment for a chronic condition (i.e. regular instillations for several months)
- Protected patient: adult under guardianship, curatorship or other protection legal, deprived of liberty by judicial or administrative decision
Key Trial Info
Start Date :
September 19 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2027
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT07206628
Start Date
September 19 2025
End Date
March 1 2027
Last Update
November 17 2025
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
Besomed SRLS
Bari, Italy
2
Studio Oculistico D'Azeglio
Bologna, Italy
3
Centro Medico Polispecialistico Di Maita
Catania, Italy
4
Studio Medico Oculistico Dr.ssa Rosa SCHIAVELLI s.r.l.
Corigliano, Italy